1ghg
From Proteopedia
| Line 1: | Line 1: | ||
[[Image:1ghg.gif|left|200px]] | [[Image:1ghg.gif|left|200px]] | ||
| - | + | <!-- | |
| - | + | The line below this paragraph, containing "STRUCTURE_1ghg", creates the "Structure Box" on the page. | |
| - | + | You may change the PDB parameter (which sets the PDB file loaded into the applet) | |
| - | + | or the SCENE parameter (which sets the initial scene displayed when the page is loaded), | |
| - | + | or leave the SCENE parameter empty for the default display. | |
| - | + | --> | |
| - | | | + | {{STRUCTURE_1ghg| PDB=1ghg | SCENE= }} |
| - | | | + | |
| - | + | ||
| - | }} | + | |
'''CRYSTAL STRUCTURE OF VANCOMYCIN AGLYCON''' | '''CRYSTAL STRUCTURE OF VANCOMYCIN AGLYCON''' | ||
| Line 19: | Line 16: | ||
==About this Structure== | ==About this Structure== | ||
| - | + | Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GHG OCA]. | |
==Reference== | ==Reference== | ||
The role of sugar residues in molecular recognition by vancomycin., Kaplan J, Korty BD, Axelsen PH, Loll PJ, J Med Chem. 2001 May 24;44(11):1837-40. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11356118 11356118] | The role of sugar residues in molecular recognition by vancomycin., Kaplan J, Korty BD, Axelsen PH, Loll PJ, J Med Chem. 2001 May 24;44(11):1837-40. PMID:[http://www.ncbi.nlm.nih.gov/pubmed/11356118 11356118] | ||
| - | [[Category: Protein complex]] | ||
[[Category: Axelsen, P H.]] | [[Category: Axelsen, P H.]] | ||
[[Category: Kaplan, J.]] | [[Category: Kaplan, J.]] | ||
[[Category: Korty, B D.]] | [[Category: Korty, B D.]] | ||
[[Category: Loll, P J.]] | [[Category: Loll, P J.]] | ||
| - | [[Category: | + | [[Category: Aglycon]] |
| - | [[Category: | + | [[Category: Glycopeptide antibiotic]] |
| - | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 17:33:55 2008'' | |
| - | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | |
Revision as of 14:34, 2 May 2008
CRYSTAL STRUCTURE OF VANCOMYCIN AGLYCON
Overview
The sugar residues of the glycopeptide antibiotic vancomycin contribute to the cooperativity of ligand binding, thereby increasing ligand affinity and enhancing antimicrobial activity. To assess the structural basis for these effects, we determined a 0.98 A X-ray crystal structure of the vancomycin aglycon and compared it to structures of several intact vancomycin:ligand complexes. The crystal structure reveals that the aglycon binds acetate anions and forms back-to-back dimeric complexes in a manner similar to that of intact vancomycin. However, the four independent copies of the aglycon in each asymmetric unit of the crystal exhibit a high degree of conformational heterogeneity. These results suggest that the sugar residues, in addition to enlarging and strengthening the dimer interface, provide steric constraints that limit the vancomycin molecule to a relatively small number of productive conformations.
About this Structure
Full crystallographic information is available from OCA.
Reference
The role of sugar residues in molecular recognition by vancomycin., Kaplan J, Korty BD, Axelsen PH, Loll PJ, J Med Chem. 2001 May 24;44(11):1837-40. PMID:11356118 Page seeded by OCA on Fri May 2 17:33:55 2008
